Cedric Francois - 10 Feb 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Executive Officer, Director
Signature
/s/David Watson, attorney-in-fact for Cedric Francois
Issuer symbol
APLS
Transactions as of
10 Feb 2022
Net transactions value
-$118,884
Form type
4
Filing time
14 Feb 2022, 17:20:27 UTC
Previous filing
01 Feb 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability $118,884 -2,523 -0.26% $47.12 955,940 10 Feb 2022 Direct F1
holding APLS Common Stock 300,000 10 Feb 2022 The Francois Grossi Trust F2
holding APLS Common Stock 234,411 10 Feb 2022 The Francois-DuBois Educational Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.
F2 The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F3 The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.